EUVIMEDEUVIMED entdecken
Open Access

Artificial Intelligence-Driven Integrated Risk Assessment of Cardiovascular Disease (AIRA-CVD): A Technical Framework Incorporating Inflammatory Biomarker Signatures and Histopathological Vascular Remodeling

Cfc Ogbuefi

Cureus · 07.04.2026

DOI: 10.7759/cureus.106615 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cureus, erschienen am 07.04.2026. Verfasst von Cfc Ogbuefi. Beteiligte Einrichtung: Department of Family Medicine, Federal University Teaching Hospital, Owerri, NGA. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cardiovascular disease (CVD) remains the leading cause of mortality in the United States, with persistent disparities driven by limitations in traditional risk stratification models and fragmented healthcare data systems. This conceptual technical report presents the Artificial Intelligence-Driven Integrated Risk Assessment of Cardiovascular Disease (AIRA-CVD) framework, a multimodal predictive architecture designed to integrate clinical diagnostic informatics, inflammatory biomarker signatures, and histopathological validation of vascular remodeling. The proposed framework leverages structured and unstructured electronic health record (EHR) data, cardiovascular imaging, and circulating biomarkers, including high-sensitivity C-reactive protein (hs-CRP) and interleukin-6 (IL-6), to generate individualized risk predictions. A distinguishing feature of AIRA-CVD is the incorporation of histopathological vascular remodeling as a ground-truth calibration standard, which is designed to enhance interpretability and is hypothesized to mitigate bias associated with traditional proxy-based models. The framework further integrates human-in-the-loop clinical oversight and continuous performance auditing to align with emerging ethical governance standards. By linking computational modeling with biological validation, AIRA-CVD is designed to provide a scalable and equity-centered approach to precision cardiovascular risk assessment and, if prospectively validated, may have the potential to contribute to improved clinical outcomes and reduced health disparities.

Schlagwörter

Stichwörter der Autor:innen

artificial intelligencecardiovascular diseasediagnostic informaticsdigital healthhealth equityinflammatory biomarkersmachine learningpredictive modelingrisk assessmentvascular remodeling

Autor:innen und Institutionen

  • Department of Family Medicine, Federal University Teaching Hospital, Owerri, NGA.

Zitieren

APA

Ogbuefi, C. (2026). Artificial Intelligence-Driven Integrated Risk Assessment of Cardiovascular Disease (AIRA-CVD): A Technical Framework Incorporating Inflammatory Biomarker Signatures and Histopathological Vascular Remodeling. Cureus. https://doi.org/10.7759/cureus.106615

Vancouver

Ogbuefi C. Artificial Intelligence-Driven Integrated Risk Assessment of Cardiovascular Disease (AIRA-CVD): A Technical Framework Incorporating Inflammatory Biomarker Signatures and Histopathological Vascular Remodeling. Cureus. 2026. doi:10.7759/cureus.106615

BibTeX
@article{Ogbuefi2026,
  author = {Ogbuefi, Cfc},
  title = {Artificial Intelligence-Driven Integrated Risk Assessment of Cardiovascular Disease (AIRA-CVD): A Technical Framework Incorporating Inflammatory Biomarker Signatures and Histopathological Vascular Remodeling},
  journal = {Cureus},
  year = {2026},
  doi = {10.7759/cureus.106615}
}
Kostenlos starten →